{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:43:26Z","timestamp":1774554206876,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report a case of neovascular and angle closure glaucoma secondary to breast cancer metastatic to the iris that was successfully treated with injections of intravitreal bevacizumab (Avastin) 1.25 mg\/0.05 mL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Case report.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>A 47-year-old woman with metastatic breast cancer presented to The New York Eye Cancer Center with left ocular pain, photosensitivity, vision loss, and multiple iris nodules. Her intraocular pressure was uncontrolled. Gonioscopy revealed neovascularization of the iris and angle; no choroidal neovascularization was noted. Ultrasound biomicroscopy demonstrated tumor invasion of iris stroma with marked anterior uveal thickening and narrowed angles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Three monthly injections of intravitreal bevacizumab resulted in nearly complete resolution of iris neovascularization, reduction of intraocular pressure, and control of tumor (although a small amount of residual tumor remained).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intravitreal anti\u2013vascular endothelial growth factor therapy for breast cancer metastatic to the iris with secondary neovascular glaucoma provided good local control for a limited follow-up period, because the patient died because of systemic complications of her disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0000000000000285","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T09:02:58Z","timestamp":1455181378000},"page":"47-50","source":"Crossref","is-referenced-by-count":15,"title":["INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS"],"prefix":"10.1097","volume":"11","author":[{"given":"Carly J.","family":"Seidman","sequence":"first","affiliation":[{"name":"The New York Eye Cancer Center, New York, New York; and"},{"name":"Ophthalmology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul T.","family":"Finger","sequence":"additional","affiliation":[{"name":"The New York Eye Cancer Center, New York, New York; and"},{"name":"Ophthalmology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua S.","family":"Silverman","sequence":"additional","affiliation":[{"name":"Radiation Oncology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Oratz","sequence":"additional","affiliation":[{"name":"Medicine, New York University School of Medicine, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00002341-200109000-00009","article-title":"Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture","volume":"17","author":"Shields","year":"2000","journal-title":"Ophthal Plast Reconst Surg"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0002-9394(03)00192-2","article-title":"Uveal metastasis from breast cancer in 264 patients","volume":"136","author":"Demirci","year":"2003","journal-title":"Am J Ophthal"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2008.10.002","article-title":"Eye cancer related glaucoma: current concepts","volume":"54","author":"Radcliffe","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R4-20230817","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0000000000000285","article-title":"Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture","volume":"34","author":"Shields","year":"2015","journal-title":"Cornea"},{"key":"R5-20230817","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12032-007-0019-7","article-title":"Solitary iris metastasis from breast cancer with dramatic course: case report","volume":"24","author":"Ozturk","year":"2007","journal-title":"Med Oncol"},{"key":"R6-20230817","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archopht.126.4.578","article-title":"Treatment of iris melanoma and secondary glaucoma using bevacizumab and plaque radiotherapy","volume":"126","author":"Bianciotto","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10384-010-0892-z","article-title":"Intravitreal bevacizumab for iris metastasis of small cell lung carcinoma with neovascular glaucoma","volume":"55","author":"Natashima","year":"2011","journal-title":"Jpn J Ophthal"},{"key":"R8-20230817","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/cp.2011.e39","article-title":"Intracameral bevacizumab administered for non small cell lung cancer metastasis to iris","volume":"1","author":"Schell","year":"2011","journal-title":"Clin Pract"},{"key":"R9-20230817","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00417-012-2218-y","article-title":"Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung","volume":"251","author":"Yokouchi","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3928\/23258160-20150213-08","article-title":"Anti-VEGF intravitreal bevacizumab (Avastin) for radiation associated neovascular glaucoma","volume":"46","author":"Nagendran","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R11-20230817","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajo.2011.09.028","article-title":"Whole body 18F FDG positron emission tomography\/computed tomography evaluation of patients with uveal metastasis","volume":"153","author":"Patel","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.survophthal.2009.06.004","article-title":"Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R13-20230817","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaapos.2010.10.007","article-title":"Langerhans cell histiocytosis of the uvea with neovascular glaucoma: diagnosis by fine-needle aspiration biopsy and management with intraocular bevacizumab and brachytherapy","volume":"14","author":"Shields","year":"2010","journal-title":"J AAPOS"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01271216-201701110-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:07:17Z","timestamp":1692292037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271216-201701110-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0000000000000285","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}